With the costs of pet ownership rising, the Competition Bureau sees an opportunity to drive down the prices of medication by expanding distribution to pharmacies.

A new report from Canada’s monopoly watchdog says pet owners deserve more choice and competitive prices for pet medications.

All told, the Competition Bureau’s pet theory about veterinary prescription services is a dog’s breakfast of policy options ...

Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days ...

Now, Georgia pet parents ... across pharmaceuticals are common, particularly in the first few years after a launch. Through ...

Most pet owners in Canada receive prescriptions and the drugs themselves ... but are largely restricted from stocking the ...

Amcor noted the deal during its first fiscal 2025 earnings call, in which new CEO Peter Konieczny also discussed the ...

Growth stocks have faced mixed sentiment from investors over the last few years despite the prolonged bull market. Concerns ...

Today, the Competition Bureau has published an analysis of the pet pharmaceutical sector, titled Pets, vets and meds: The case for more competition. It examines the business practice in Canada of ...

Today, the Competition Bureau has published an analysis of the pet pharmaceutical sector, titled Pets, vets and meds: The case for more competition. It examines the business practice in Canada of ...

Mandating the supply of pet medication to pharmacists would improve competition and consumer choice.In recent years, more Canadians have brought pets ...